Search Results 1341-1350 of 19371 for hemoglobin

  1. A Study to Evaluate the Addition of Immunotherapy into Adjuvant Therapy for Non-small Cell Lung Cancer - Mayo Clinic

    Hemoglobin ≥ 8 gm/dl;; Calculated (Calc.) creatinine clearance ≥ 45 mL/min;; Total bilirubin ≤ 1.5 x upper limit of normal (ULN);; Aspartate ...

  2. Lenalidomide or Observation in Treating Patients with Asymptomatic High-Risk Smoldering Multiple Myeloma - Mayo Clinic

    Hemoglobin ≥ 11 g/dL; Platelet count ≥ 100,000/mm^3; Absolute neutrophil count (ANC) ≥ 1,500/mm^3; Calculated creatinine clearance ≥ 30 mL/min; Bilirubin ...

  3. A Study to Assess the Effectiveness and Safety of Apremilast in Pediatric Patients (6 through 17 years old) with Moderate-to-Severe Plaque Psoriasis - Mayo Clinic

    Hemoglobin (Hb); Age (years) | Males (g/dL) | Females (g/dL). 6-11 | 10.0 – 15.0 | 10.0 – 15.0; 12-18 | 11.0 – 16.5 | 10.5 – 15.5. All females of childbearing ...

  4. Dasatinib (oral route) - Side effects & dosage - Mayo Clinic

    It is also used to treat Ph+ CML and Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL) in adults after other medicines (eg, imatinib) or ...

  5. A Study to Evaluate Intravenous Iloprost in Subjects with Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis - Mayo Clinic

    ... hemoglobin). Subjects with scleroderma renal crisis within 6 months of screening. Subjects with a concomitant life-threatening disease with a life ...

  6. A Study to Evaluate the Effectiveness and Safety of Brolucizumab vs. Aflibercept in Patients with Visual Impairment Due to Diabetic Macular Edema - Mayo Clinic

    Patients with type 1 or type 2 diabetes mellitus (DM) and Hemoglobin A1c (HbA1c) ≤ 12% at screening. Study eye: Visual impairment due to DME with: Best ...

  7. Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure - Mayo Clinic

    Hemoglobin levels ≤ 8.0 or ≥ 18.0 g/dL for men and > 15 for women at Screening, with hematocrit ≥ 54% for men and ≥ 45% for women; Current malignancy ...

  8. Veliparib and Topotecan Hydrochloride in Treating Patients With Solid Tumors, Relapsed or Refractory Ovarian Cancer, or Primary Peritoneal Cancer - Mayo Clinic

    Hemoglobin ≥ 9.0 g/dL;; Platelets ≥ 100,000/mcL;; Total bilirubin ≤ 1.5 x the upper limit of normal (ULN);; SGPT (ALT) or SGOT (AST) ≤ 2.5 x ULN in the ...

  9. Everolimus, Rituximab, and Combination Chemotherapy in Treating Patients with Newly Diagnosed Untreated Diffuse Large B-Cell Lymphoma - Mayo Clinic

    Hemoglobin (HgB) > 9.0 g/dL; Total bilirubin ≤ 1.5 times upper limit of normal (ULN). For total bilirubin > 1.5 times ULN, the direct bilirubin must be ...

  10. Dual BET And CBP/p300 Inhibitor In Patients With Targeted Advanced Solid Tumors And Hematological Malignancies - Mayo Clinic

    * Hemoglobin ≥ 9.0 g/dL (Part 1) * Absolute neutrophil count (ANC) ≥ 1,500/dL (Part 1) * Platelet count ≥100,000/μL (Part 1) or ≥75,000/μL (Part 3)